Sort
16,300 grants matching “fatty liver disease”
Protective role of adenosine 2A receptor in NAFLD
$328,976Chaodong Wu · Texas A&M Agrilife Research · R01 · FY2013 · DK
Mechanisms of Lipid-Induced Hepatic Insulin Resistance
$328,967Gerald I Shulman · Yale University · R01 · FY2013 · DK
DIETARY FAT REGULATION OF HEPATIC GENE EXPRESSION
$328,951Michigan State University · R01 · FY2005 · DK
Impact of FGF21-mediated immune-metabolic interactions on immune-senescence
$328,943Vishwa Deep Dixit · Yale University · P01 · FY2020 · AG
The Role of Leptin in Liver Fibrogenesis
$328,932Frank A. Anania · Emory University · R01 · FY2008 · DK
ETHANOL REGULATION OF ADIPONECTIN AND ITS SIGNALING
$328,900Min You · University Of South Florida · R01 · FY2012 · AA
Epigenetic Programming of Health and Disease in the Preimplantation Embyro
$328,887Paolo Rinaudo · University Of California, San Francisco · R01 · FY2016 · HD
Epigenetic Programming of Health and Disease in the Preimplantation Embyro
$328,887Paolo Rinaudo · University Of California, San Francisco · R01 · FY2017 · HD
CNS action of appetite suppressant aminosterol
$328,725Rexford S Ahima · University Of Pennsylvania · R01 · FY2008 · DK
Hepatic Fatty Acid Metabolism and Steatosis
$328,690Nicholas Davidson · Washington University · R01 · FY2006 · DK
Role of IKK-beta/NF-kappaB in hypothalamic dysregulation of energy balance
$328,680Dongsheng Cai · Albert Einstein College Of Medicine · R01 · FY2010 · DK
The Role of O-Glycosylation on the InsP3R in Liver Metabolism
$328,643Barbara E. Ehrlich · Yale University · P01 · FY2013 · DK
Ligand specificity in human glucose transporters GLUT1-5 and GLUT9
$328,616Jun-Yong Choe · Rosalind Franklin Univ Of Medicine & Sci · R01 · FY2017 · GM
Role of Cytokine Signaling Pathways and Macrophages in Type 2 Diabetes Mellitus
$328,604Ajay Chawla · Stanford University · R01 · FY2009 · DK
Augmented Phenylalanine Clearance by Muscles as Novel Therapy for Phenylketonuria
$328,528Cary O. Harding · Oregon Health & Science University · R01 · FY2010 · HD
Adipose Triglyceride Lipase (ATGL) in Lipotoxicity and The Metabolic Syndrome
$328,493Erin E Kershaw · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · DK
Adipose Triglyceride Lipase (ATGL) in Lipotoxicity and The Metabolic Syndrome
$328,490Erin E Kershaw · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · DK
Adipose Triglyceride Lipase (ATGL) in Lipotoxicity and The Metabolic Syndrome
$328,486Erin E Kershaw · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · DK
The role of hepatic Sortlin 1 in diabetic dyslipidemia
$328,425Tiangang Li · University Of Kansas Medical Center · R01 · FY2017 · DK
The role of hepatic Sortlin 1 in diabetic dyslipidemia
$328,425Tiangang Li · University Of Kansas Medical Center · R01 · FY2016 · DK
FXR, nuclear receptors, and transcriptional regulation of liver homeostasis
$328,425Grace L Guo · University Of Kansas Medical Center · R56 · FY2011 · DK
The role of hepatic Sortlin 1 in diabetic dyslipidemia
$328,425Tiangang Li · University Of Kansas Medical Center · R01 · FY2015 · DK
The role of hepatic Sortlin 1 in diabetic dyslipidemia
$328,425Tiangang Li · University Of Kansas Medical Center · R01 · FY2014 · DK
Viral Hepatitis C and Lipid Homeostasis
$328,313Aleem Siddiqui · University Of California, San Diego · R01 · FY2008 · DK
Viral Hepatitis C and Lipid Homeostasis
$328,313Aleem Siddiqui · University Of California, San Diego · R01 · FY2009 · DK